Explore our materials

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

(Abstract) Cost-efficiency versus Potency | Anca Streinu-Cercel, MD, PhD

Oana Săndulescu

MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Local situation in Romania | Oana Săndulescu, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

(Abstract) Predictors of HIV co-infection in HCV infected patients in Serbia | M. Stanojevic

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

(Abstract) Quality of life in patients with HCV/ HIV co-infection | O. Shevchenko

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

(Abstract) Chronic Hepatitis C Treatment among HIV/HCV co-infected PWID in Ukraine: communitysupported treatment model experience | T. Barnard

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

(Abstract) Expression of NS4 HCV in liver cells of HIV/HCV co-infected patients | N. Matsiyeuskaya

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

(Abstract) HCV reinfection in HCV/HIV coinfected patients treated for VHC in AIDS Center Prague | V. Aster

Mariana Mărdărescu

MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

HIV and Pediatrics in Central Europe | Mariana Mărdărescu, MD, PhD

AMG

Anna Maria Geretti

MD, PhD, FRCPath

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Tackling the issues: Caring for HIV-positive women today | Anna Maria Geretti, MD, PhD, FRCPath

Anca Streinu-Cercel

MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Drug-Drug Interactions: considerations | Anca Streinu-Cercel, MD, PhD

Cihan Yurdaydin

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Update of new drugs | Cihan Yurdaydin, MD

Pavel Khaykin